Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

U.S. federal health officials announced a new rule in November that allows kidney and liver transplants between HIV-positive ...

Community leaders gathered in South Charleston Wednesday evening following a recent spike in HIV and Hepatitis C within ...

With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

A new, long-acting injectable to prevent HIV infection could be a “game-changer” in ending the AIDS epidemic, if all who ...

Modern therapies help people living with HIV to survive, but scientists are still trying to decipher the deep mystery of how ...

In recognition of World AIDS Day, The Living Bridge Center in Dalton is offering rapid H-I-V testing. For those at risk or ...

Advanced Dermatology P.C., with 14 offices on LI, violated the American Disabilities Act, the U.S. Attorney said.

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Global partners have supported Africa’s progress in HIV vaccine research and development. Organisations such as the US ...

As residents come together to recognize World AIDS Day, experts say early detection and modern drug regimens could eventually ...